The Department of Health and Human Services is offering the Limited Competition: Alzheimer’s Disease Cooperative Study (U19) grant to continue the Alzheimer’s Disease Cooperative Study (ADCS) as the leading AD clinical trials consortium. The grant aims to support the advancement of research in developing interventions for treating, delaying, or preventing AD, especially interventions that may not be pursued by the industry. Applications for the next 5-year cycle of the ADCS are being sought in this limited competition FOA, with a closing date of Mar 07, 2012.
Opportunity ID: 131973
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | RFA-AG-13-001 |
| Funding Opportunity Title:: | Limited Competition: Alzheimer’s Disease Cooperative Study (U19) |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Health |
| Category Explanation:: | |
| Expected Number of Awards:: | |
| Assistance Listings Number(s):: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Nov 28, 2011 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Mar 07, 2012 |
| Current Closing Date for Applications:: | Mar 07, 2012 |
| Archive Date:: | Apr 07, 2012 |
| Estimated Total Program Funding:: | $ 13,000,000 |
| Award Ceiling:: | $ |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility:: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name:: | National Institutes of Health |
| Description:: | This limited competition FOA is to continue the Alzheimer’s Disease Cooperative Study (ADCS) as the pre-eminent Alzheimer’s disease (AD) clinical trials consortium. The purpose of this FOA is to solicit the renewal application for the next 5-year cycle of the ADCS. The goals of this next phase are to continue to advance research in the development of interventions that might be useful for treating, delaying, or preventing AD, particularly interventions that might not be developed by industry. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Package No: 1